ViewsML / funding news

Coverage — click on a media logo to view article.

About

ViewsML, an AI digital pathology company developing virtual biomarker staining, closed a $4.9 million seed round in April 2026 with backing from Mayo Clinic. The announcement needed to reach health system leaders, laboratory professionals, AI watchers, and investors at once.